Skip to main content

Too Many Breast Cancer Survivors Miss Out on Genetic Screening

Medically reviewed by Carmen Pope, BPharm. Last updated on July 19, 2024.

By Dennis Thompson HealthDay Reporter

FRIDAY, July 19, 2024 -- Many breast cancer patients aren’t getting genetic counseling and testing that could help them get the most effective treatment, a new study finds.

Only three-quarters of patients eligible for genetic testing after their breast cancer diagnosis actually received it, researchers reported July 15 in the Journal of Clinical Oncology.

Further, just over half of breast cancer survivors eligible for testing during follow-up care received a genetic screening.

“Our findings support a rapidly growing movement to simplify clinical guidelines to increase access to genetic testing and clinical impact of the results after diagnosis and into survivorship,” said lead researcher Dr. Steven Katz, a professor of internal medicine and of health management and policy at the University of Michigan.

Certain genetic mutations can increase a woman’s risk for breast cancer, the American Cancer Society says. The best-known are BRCA gene mutations, which cause 5% to 10% of breast cancers and for which specific treatments have been developed.

Genetic tests can help guide treatment, as well as follow-up care and screening, researchers said. The results can also be used to warn other family members of potential increased risk for cancer.

For this study, researchers surveyed more than 1,400 women at seven months and at six years after they were diagnosed with early-stage breast cancer.

The team found many women aren’t getting the gene testing for which they’re eligible, both at diagnosis and following treatment.

“Genetic risk evaluation and testing can fall through the cracks during survivorship as patients’ needs for ongoing treatments, managing the side effects of treatments and monitoring for recurrence or progression grow,” senior researcher Lauren Wallner, an associate professor of internal medicine and epidemiology at Michigan, said in a university news release.

At the same time, about a third of patients for whom genetic testing wouldn’t be recommended got it anyway, results showed.

There was some good news -- among those who got testing, nearly two-thirds who had a genetic variant reached out to family members to talk about their results, researchers said.

Results also showed that few people are interested in direct-to-consumer genetic tests, which are not as sophisticated as genetic testing and counseling at hospitals and clinics, researchers said.

Sources

  • University of Michigan, news release, July 16, 2024

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2025 HealthDay. All rights reserved.

Posted July 2024

Read this next

A Gene May Influence How Much Cats Purr and Meow

SUNDAY, June 8, 2025 — Why does your cat purr when you pet it — or meow when dinner’s late? A new study from the Wildlife Research Center at Kyoto University in...

An Expert's Guide to Keeping Middle-Age Spread at Bay

SATURDAY, June 7, 2025 — You're not just getting older, you're probably getting bigger. Between their 20s and 40s, most Americans can expect to put on 10 to 25 pounds...

FDA Authorizes First AI Platform for Breast Cancer Prediction

FRIDAY, June 6, 2025 -- The U.S. Food and Drug Administration has granted de novo authorization to CLAIRITY BREAST, a first-in-class, image-based platform that can help predict a...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.